Can you quantify "cheap" for me please?
I've said this before, a $600M MC company with a few sales, a FDA and a marketing plan seems pretty expensive. People use the term "cheap" and use their own wishful thinking as valuation.
If we reverse engineer current valuation, on a 25xPE, would mean NPAT of $24M. Based on best estimates provided by analysts, this woud suggest that 850,000 prescriptions to be filled in the USA.
I get that the market is forward looking, but its already valued at 2025/26 sales estimates.
Bot Chart, page-13300
-
- There are more pages in this discussion • 955 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $678.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.0¢ | $890.6K | 2.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 351716 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 655831 | 12 |
View Market Depth
| Last trade - 11.09am 16/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |